Development of a Genetic Counseling Patient Preference Intervention for Women at Elevated Risk for Breast Cancer

Completed

• Conditions: Breast Carcinoma
• Interventions: Procedure: Discussion

• Registration Number: NCT05158452
• Lead Sponsor: Ohio State University Comprehensive Cancer Center

Brief Summary

This study develops a genetic counseling patient preference intervention for women at elevated risk for breast cancer. This study aims to develop an intervention that may deliver educational videos about breast cancer, heredity, multigene tests results and polygenic risk score, provide multigene and polygenic test results, obtain information about patients' questions/ concerns about test results to use in post-genetic test counseling, and determine patient preference (e.g. telephone) for receipt of post-genetic test counseling.

Detailed Description

PRIMARY OBJECTIVE:

I. Develop the Genetic Counseling Patient Preference (GCPP) intervention in collaboration with community members.

OUTLINE:

Participants attend a focus group over 90-120 minutes providing feedback on GCPP intervention.

Study Timeline

• Study Start: 2020-12-09
• Study First Submitted: 2021-12-03
• Study First Submitted QC: 2021-12-03
• Study First Posted: 2021-12-15
• Primary Completion: 2022-10-30
• Study Completion: 2022-10-30
• Status Verified: 2022-11
• Last Update Submitted: 2022-11-08
• Last Update Posted: 2022-11-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 8

Inclusion Criteria

• Female
• Ages 35-64
• Known elevated risk for breast cancer
• The ability to speak and read English
• Provide written consent

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Observational (focus group)	Discussion	Participants attend a focus group over 90-120 minutes providing feedback on GCPP intervention.

Primary Outcome Measures

Name	Time	Method
Development of Genetic Counseling Patient Preference (GCPP) intervention	Up to 2 years

Trial Locations

Locations (1)

Ohio State University Comprehensive Cancer Center; 🇺🇸 Columbus, Ohio, United States